| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 SPNS1 ABCA1 PIEZO1 OTOP2 SLC35E1 PKD1L2 SLC22A24 RYR1 RYR2 CALHM4 SLC9C1 SLC38A10 SCN7A KCNN1 KCNN3 HTR3D CACNA1I ABCC2 CACNA1A CACNA1B CACNA1D CACNA1E SLC2A8 SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 TMEM37 SLC28A1 ATP2B3 SLC33A1 SLC37A4 | 5.06e-09 | 1180 | 236 | 39 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 SPNS1 ABCA1 PIEZO1 OTOP2 SLC35E1 PKD1L2 SLC22A24 RYR1 RYR2 CALHM4 SLC9C1 SLC38A10 SCN7A KCNN1 KCNN3 HTR3D CACNA1I ABCC2 TMEM41B TMEM184B CACNA1A CACNA1B CACNA1D CACNA1E SLC2A8 SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 TMEM37 SLC28A1 ATP2B3 SLC33A1 SLC37A4 | 5.79e-09 | 1289 | 236 | 41 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 SLC28A1 ATP2B3 | 2.42e-08 | 664 | 236 | 27 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A ANO10 TMEM37 | 1.52e-07 | 343 | 236 | 18 | GO:0005261 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | PKD1L2 RYR1 RYR2 SLC9C1 SCN7A KCNN1 KCNN3 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A SLC39A10 SLC5A3 SLC20A1 SLC20A2 TMEM37 SLC28A1 ATP2B3 | 1.72e-07 | 465 | 236 | 21 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 SLC28A1 ATP2B3 | 2.48e-07 | 793 | 236 | 28 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 OTOP2 PKD1L2 RYR1 RYR2 SLC9C1 SCN7A KCNN1 KCNN3 CACNA1I ABCC2 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 SLC28A1 ATP2B3 SLC37A4 | 3.49e-07 | 758 | 236 | 27 | GO:0015318 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.06e-07 | 14 | 236 | 5 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A ANO10 TMEM37 | 6.01e-07 | 459 | 236 | 20 | GO:0005216 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | OTOP2 PKD1L2 RYR1 RYR2 SLC9C1 SCN7A KCNN1 KCNN3 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 SLC28A1 ATP2B3 | 1.66e-06 | 627 | 236 | 23 | GO:0022890 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.67e-06 | 18 | 236 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | PKD1L2 RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A TMEM37 ATP2B3 | 1.87e-06 | 151 | 236 | 11 | GO:0015085 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.29e-06 | 9 | 236 | 4 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.29e-06 | 9 | 236 | 4 | GO:0099626 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 PIEZO1 RYR1 RYR2 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A ANO10 TMEM37 | 2.49e-06 | 334 | 236 | 16 | GO:0022836 |
| GeneOntologyMolecularFunction | calcium channel activity | PKD1L2 RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A TMEM37 | 3.16e-06 | 129 | 236 | 10 | GO:0005262 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A ANO10 TMEM37 | 4.67e-06 | 525 | 236 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 SCN7A KCNN1 KCNN3 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A ANO10 TMEM37 | 4.80e-06 | 526 | 236 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.61e-05 | 46 | 236 | 6 | GO:0005245 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.74e-05 | 28 | 236 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 ABCA1 HLA-DQB2 OR4D9 HLA-DRA GPR85 OR13G1 OR2F1 OR6M1 OR4D2 SORCS1 SORT1 GHRHR OR6J1 SCN7A HTR3D KIR3DL2 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 GRIN2A RET GRM8 OR10Z1 OR6N1 OR51L1 PLXNC1 ROS1 ADGRD2 OR4K3 GABBR1 | 5.94e-05 | 1353 | 236 | 33 | GO:0004888 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | RYR1 KCNN1 KCNN3 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A TMEM37 | 6.38e-05 | 182 | 236 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | RYR1 KCNN1 KCNN3 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A TMEM37 | 6.99e-05 | 184 | 236 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.08e-05 | 37 | 236 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | RYR1 KCNN1 KCNN3 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A | 8.38e-05 | 152 | 236 | 9 | GO:0022843 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA1 SLC35E1 SLC9C1 ABCC2 SLC2A8 SLC13A3 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 SLC28A1 ATP2B3 SLC37A4 | 1.88e-04 | 477 | 236 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 2.01e-04 | 431 | 236 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC35E1 SLC9C1 SLC2A8 SLC13A3 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A4 SLC28A1 SLC37A4 | 2.22e-04 | 296 | 236 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential | 4.14e-04 | 3 | 236 | 2 | GO:0150047 | |
| GeneOntologyMolecularFunction | symporter activity | SLC13A3 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A4 SLC28A1 | 4.21e-04 | 150 | 236 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.38e-04 | 119 | 236 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | acetate ester transmembrane transporter activity | 8.22e-04 | 4 | 236 | 2 | GO:1901375 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 8.22e-04 | 4 | 236 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | small conductance calcium-activated potassium channel activity | 8.22e-04 | 4 | 236 | 2 | GO:0016286 | |
| GeneOntologyMolecularFunction | acetylcholine transmembrane transporter activity | 8.22e-04 | 4 | 236 | 2 | GO:0005277 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GABRB1 OR4D9 GPR85 OR13G1 OR2F1 OR6M1 OR4D2 SORCS1 GHRHR OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 GRM8 OR10Z1 OR6N1 OR51L1 ADGRD2 OR4K3 GABBR1 | 8.36e-04 | 884 | 236 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.97e-04 | 171 | 236 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 1.17e-03 | 18 | 236 | 3 | GO:0004708 | |
| GeneOntologyMolecularFunction | galactosylceramidase activity | 1.36e-03 | 5 | 236 | 2 | GO:0004336 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 1.37e-03 | 19 | 236 | 3 | GO:0031434 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.40e-03 | 140 | 236 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.43e-03 | 70 | 236 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | succinate transmembrane transporter activity | 2.02e-03 | 6 | 236 | 2 | GO:0015141 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.02e-03 | 6 | 236 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.15e-03 | 193 | 236 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.44e-03 | 197 | 236 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A10 ABCC2 SLC2A8 SLC13A3 GRIN2A SLC39A10 SLC16A1 SLC22A2 SLC33A1 SLC37A4 | 2.65e-03 | 293 | 236 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.73e-03 | 81 | 236 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 2.75e-03 | 24 | 236 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.81e-03 | 118 | 236 | 6 | GO:0003774 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 TCAF1 PIEZO1 OTOP2 GCG PKD1L2 SLC22A24 ACE RYR1 RYR2 CALHM4 ADD2 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 HTR3D CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 SPG11 GRIN2A ANO10 SLC39A10 CLDN10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 TMEM37 ATP2B3 | 6.27e-08 | 1374 | 230 | 39 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | PIEZO1 OTOP2 GCG PKD1L2 ACE RYR1 RYR2 CALHM4 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 SPG11 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 TMEM37 ATP2B3 | 6.70e-07 | 1157 | 230 | 33 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 ATP2B3 | 2.34e-06 | 942 | 230 | 28 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 TCAF1 PIEZO1 OTOP2 PKD1L2 RYR1 RYR2 CALHM4 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 HTR3D CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 ATP2B3 | 2.57e-06 | 1115 | 230 | 31 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 OTOP2 PKD1L2 RYR1 RYR2 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 HTR3D CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 ATP2B3 SLC37A4 | 3.43e-06 | 1017 | 230 | 29 | GO:0098660 |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC9C1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC39A10 SHOC2 SLC5A3 SLC22A2 SLC22A4 SLC28A1 | 1.12e-05 | 230 | 230 | 12 | GO:0098739 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | OTOP2 PKD1L2 RYR1 RYR2 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 HTR3D CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GRIN2A SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 TMEM37 ATP2B3 | 1.39e-05 | 922 | 230 | 26 | GO:0098662 |
| GeneOntologyBiologicalProcess | metal ion transport | GCG PKD1L2 ACE RYR1 RYR2 SLC9C1 PIK3CG SCN7A KCNN1 KCNN3 CACNA1I ABCC2 AP3D1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 SPG11 GRIN2A SLC39A10 SLC5A3 SLC20A1 SLC20A2 SLC22A4 TMEM37 ATP2B3 | 2.03e-05 | 1000 | 230 | 27 | GO:0030001 |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 4.36e-05 | 148 | 230 | 9 | GO:1904659 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 5.11e-05 | 151 | 230 | 9 | GO:0008645 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 5.95e-05 | 154 | 230 | 9 | GO:0015749 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC22A24 ACE ERFE SLC38A10 NF1 ABCC2 CACNA1A SLC2A8 SLC13A3 SLC39A10 SHOC2 PLA2R1 SLC16A1 SLC22A2 SLC33A1 SLC37A4 GABBR1 | 7.10e-05 | 515 | 230 | 17 | GO:0015711 |
| GeneOntologyBiologicalProcess | neuron development | GABRB1 UBE4B LAMA1 TSC2 WLS CNTN6 SEMA4C GDPD5 NF1 BRAF WASHC5 PLS1 CARM1 CACNA1A LHX4 NRCAM TNC FAT3 SPG11 LHX3 ZSWIM6 RET SHOC2 GBA2 TDP2 NR2F1 WDPCP PLXNC1 MACF1 POTEJ MAP2K1 MAP2K2 MYO16 | 8.61e-05 | 1463 | 230 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | SOX4 PCSK2 TM7SF3 BCAT2 GCG ACE GHRHR ARHGEF7 NFKB1 SCT ABCC2 CACNA1A CACNA1D CACNA1E DHRS11 LIPE SLC16A1 FURIN ASMT GABBR1 | 8.80e-05 | 684 | 230 | 20 | GO:0010817 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 1.09e-04 | 432 | 230 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | calcium ion import | 1.14e-04 | 98 | 230 | 7 | GO:0070509 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 1.16e-04 | 168 | 230 | 9 | GO:0034219 | |
| GeneOntologyBiologicalProcess | medial motor column neuron differentiation | 1.24e-04 | 2 | 230 | 2 | GO:0021526 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4D9 PIEZO1 OR13G1 PKD1L2 OR2F1 OR6M1 RYR2 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 GRIN2A GRM8 OR10Z1 OR6N1 OR51L1 OR4K3 | 1.81e-04 | 722 | 230 | 20 | GO:0051606 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.91e-04 | 48 | 230 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.91e-04 | 48 | 230 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | GABRB1 GAD2 ABCA1 UBE4B VPS13C TSC2 GCG ACE RYR1 RYR2 SORT1 GHRHR ERFE FAT1 BRAF UMODL1 PIK3CG NFKB1 HTR3D CARM1 CACNA1A CACNA1B SLC2A8 LARP1 GRIN2A SHOC2 TRIB3 EDEM1 MAP2K1 | 2.01e-04 | 1272 | 230 | 29 | GO:1901698 |
| GeneOntologyBiologicalProcess | export from cell | SOX4 ABCA1 TM7SF3 GCG WLS GHRHR NF1 BRAF WASHC5 ARHGEF7 PIK3CG SCT CACNA1I ABCC2 RIC1 NLRP5 CACNA1A CACNA1B CACNA1D CACNA1E STAM GRM8 SLC16A1 FURIN SLC22A2 ATP2B3 GABBR1 | 2.21e-04 | 1153 | 230 | 27 | GO:0140352 |
| GeneOntologyBiologicalProcess | secretion | SOX4 ABCA1 TM7SF3 GCG WLS ACE GHRHR NF1 BRAF WASHC5 ARHGEF7 PIK3CG SCT CACNA1I ABCC2 RIC1 NLRP5 CACNA1A CACNA1B CACNA1D CACNA1E STAM GRM8 PLA2R1 SLC16A1 FURIN SLC22A2 GABBR1 | 2.37e-04 | 1221 | 230 | 28 | GO:0046903 |
| GeneOntologyBiologicalProcess | neuron projection development | UBE4B LAMA1 TSC2 WLS CNTN6 SEMA4C GDPD5 NF1 BRAF WASHC5 PLS1 CARM1 CACNA1A LHX4 NRCAM TNC FAT3 SPG11 LHX3 ZSWIM6 RET SHOC2 NR2F1 PLXNC1 MACF1 POTEJ MAP2K1 MAP2K2 MYO16 | 2.38e-04 | 1285 | 230 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 2.43e-04 | 465 | 230 | 15 | GO:0007608 |
| GeneOntologyBiologicalProcess | carbohydrate transport | 2.50e-04 | 186 | 230 | 9 | GO:0008643 | |
| GeneOntologyBiologicalProcess | positive regulation of growth hormone secretion | 2.80e-04 | 12 | 230 | 3 | GO:0060124 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4D9 OR13G1 OR2F1 OR6M1 RYR2 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 2.80e-04 | 524 | 230 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | LAMA1 TSC2 WLS CNTN6 SEMA4C BRAF PLS1 CACNA1A LHX4 NRCAM FAT3 SPG11 LHX3 RET WDPCP PLXNC1 MACF1 POTEJ MAP2K1 MAP2K2 | 2.87e-04 | 748 | 230 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 GRIN2A GRM8 OR10Z1 OR6N1 OR51L1 OR4K3 | 3.03e-04 | 582 | 230 | 17 | GO:0050906 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | GABRB1 TSC2 GCG ACE RYR1 RYR2 GHRHR ERFE FAT1 UMODL1 PIK3CG NFKB1 HTR3D CACNA1A SLC2A8 LARP1 GRIN2A SHOC2 TRIB3 MAP2K1 | 3.08e-04 | 752 | 230 | 20 | GO:1901699 |
| GeneOntologyBiologicalProcess | acetate ester transport | 3.60e-04 | 13 | 230 | 3 | GO:1901374 | |
| GeneOntologyBiologicalProcess | L-valine biosynthetic process | 3.69e-04 | 3 | 230 | 2 | GO:0009099 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 3.74e-04 | 31 | 230 | 4 | GO:0006817 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 3.79e-04 | 485 | 230 | 15 | GO:0050907 |
| GeneOntologyBiologicalProcess | spinal cord development | 3.81e-04 | 119 | 230 | 7 | GO:0021510 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 3.89e-04 | 157 | 230 | 8 | GO:0090277 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast migration | 3.97e-04 | 56 | 230 | 5 | GO:0010762 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 4.61e-04 | 161 | 230 | 8 | GO:0002793 | |
| GeneOntologyBiologicalProcess | cellular response to nerve growth factor stimulus | 5.06e-04 | 59 | 230 | 5 | GO:1990090 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | AGAP5 NEK10 TSC2 GCG SSBP1 TBC1D20 NF1 ARHGEF7 PIK3CG STRADA RIC1 AGAP1 CACNA1D GRIN2A RET SLC39A10 SLC5A3 TRIB3 SLC22A2 ROS1 AGAP9 MAP2K1 MAP2K2 SLC37A4 | 5.23e-04 | 1028 | 230 | 24 | GO:0043085 |
| GeneOntologyBiologicalProcess | phosphate ion transmembrane transport | 5.64e-04 | 15 | 230 | 3 | GO:0035435 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.25e-05 | 46 | 236 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.85e-05 | 73 | 236 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | RYR1 RYR2 SCN7A KCNN1 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC5A3 | 7.83e-05 | 235 | 236 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 RYR1 RYR2 SCN7A KCNN1 HTR3D CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A SLC5A3 TMEM37 | 1.08e-04 | 378 | 236 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | cell projection membrane | PDE6A PIEZO1 WLS ACE SLC9C1 ABCC2 CACNA1D SH2D3C FERMT1 GRIN2A SLC20A2 SLC28A1 MACF1 GABBR1 PSD4 | 1.23e-04 | 431 | 236 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.34e-04 | 223 | 236 | 10 | GO:0098862 | |
| GeneOntologyCellularComponent | outer dynein arm | 2.90e-04 | 12 | 236 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | presynaptic membrane | GABRB1 GAD2 CNTN6 CACNA1A CACNA1D CACNA1E GRIN2A GRM8 SLC22A2 ATP2B3 GABBR1 | 3.28e-04 | 277 | 236 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | brush border | 3.41e-04 | 152 | 236 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | dynein complex | 3.54e-04 | 54 | 236 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | leading edge membrane | 6.62e-04 | 210 | 236 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GAD2 DLGAP1 CLSTN2 CNTN6 SEMA4C HTR3D CACNA1A CACNA1D CACNA1E NRCAM GRIN2A GRM8 SLC22A2 ATP2B3 GABBR1 | 1.01e-03 | 583 | 236 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | glutamatergic synapse | DLGAP1 TSC2 CLSTN2 ADD2 SEMA4C SORT1 NF1 BRAF AP3D1 PRUNE2 CACNA1A CACNA1B NRCAM GRIN2A GRM8 PLXNC1 PLCXD3 MAP2K1 ATP2B3 GABBR1 | 1.02e-03 | 817 | 236 | 20 | GO:0098978 |
| HumanPheno | Superior pectus carinatum | 2.33e-05 | 4 | 93 | 3 | HP:0000917 | |
| HumanPheno | Neurofibrosarcoma | 2.33e-05 | 4 | 93 | 3 | HP:0100697 | |
| HumanPheno | Pes cavus | GALC RYR1 NF1 WASHC5 C19orf12 KCNN3 ASCC3 DYNC1H1 NRCAM SPG11 GRIN2A ANO10 RET CCDC141 GBA2 LIPE SLC33A1 | 2.69e-05 | 304 | 93 | 17 | HP:0001761 |
| Domain | VDCCAlpha1 | 6.79e-08 | 10 | 232 | 5 | IPR002077 | |
| Domain | ATPase_dyneun-rel_AAA | 5.18e-07 | 14 | 232 | 5 | IPR011704 | |
| Domain | AAA_5 | 5.18e-07 | 14 | 232 | 5 | PF07728 | |
| Domain | Ca_chan_IQ | 7.89e-07 | 7 | 232 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 7.89e-07 | 7 | 232 | 4 | PF08763 | |
| Domain | VDCC_a1su_IQ | 7.89e-07 | 7 | 232 | 4 | IPR014873 | |
| Domain | GPHH | 7.89e-07 | 7 | 232 | 4 | PF16905 | |
| Domain | GPHH_dom | 7.89e-07 | 7 | 232 | 4 | IPR031649 | |
| Domain | DHC_N1 | 1.56e-06 | 8 | 232 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.56e-06 | 8 | 232 | 4 | IPR013594 | |
| Domain | Ion_trans_dom | RYR1 RYR2 SLC9C1 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E | 1.26e-05 | 114 | 232 | 9 | IPR005821 |
| Domain | Ion_trans | RYR1 RYR2 SLC9C1 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E | 1.26e-05 | 114 | 232 | 9 | PF00520 |
| Domain | Dynein_heavy_chain_D4_dom | 2.11e-05 | 14 | 232 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.11e-05 | 14 | 232 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.11e-05 | 14 | 232 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.11e-05 | 14 | 232 | 4 | PF08393 | |
| Domain | MT | 2.11e-05 | 14 | 232 | 4 | PF12777 | |
| Domain | AAA_8 | 2.11e-05 | 14 | 232 | 4 | PF12780 | |
| Domain | DHC_fam | 2.84e-05 | 15 | 232 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.84e-05 | 15 | 232 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.84e-05 | 15 | 232 | 4 | IPR004273 | |
| Domain | Channel_four-helix_dom | 7.36e-05 | 57 | 232 | 6 | IPR027359 | |
| Domain | - | 7.36e-05 | 57 | 232 | 6 | 1.20.120.350 | |
| Domain | AAA | 8.02e-05 | 144 | 232 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 8.02e-05 | 144 | 232 | 9 | IPR003593 | |
| Domain | Phos_transporter | 1.54e-04 | 2 | 232 | 2 | IPR001204 | |
| Domain | PHO4 | 1.54e-04 | 2 | 232 | 2 | PF01384 | |
| Domain | MFS_dom | SPNS1 SLC22A24 SLC2A8 SLC16A1 SLC22A2 SLC22A4 SLC33A1 SLC37A4 | 2.73e-04 | 134 | 232 | 8 | IPR020846 |
| Domain | MFS | 4.01e-04 | 108 | 232 | 7 | PS50850 | |
| Domain | Ryanodine_rcpt | 4.57e-04 | 3 | 232 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.57e-04 | 3 | 232 | 2 | IPR009460 | |
| Domain | RyR | 4.57e-04 | 3 | 232 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 4.57e-04 | 3 | 232 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.57e-04 | 3 | 232 | 2 | IPR013333 | |
| Domain | CaMBD | 9.07e-04 | 4 | 232 | 2 | PF02888 | |
| Domain | CaM-bd_dom | 9.07e-04 | 4 | 232 | 2 | IPR004178 | |
| Domain | CaMBD | 9.07e-04 | 4 | 232 | 2 | SM01053 | |
| Domain | K_chnl_Ca-activ_SK | 9.07e-04 | 4 | 232 | 2 | IPR015449 | |
| Domain | SK_channel | 9.07e-04 | 4 | 232 | 2 | PF03530 | |
| Domain | Olfact_rcpt | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 | 1.32e-03 | 393 | 232 | 13 | IPR000725 |
| Domain | Sortilin_C | 1.50e-03 | 5 | 232 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.50e-03 | 5 | 232 | 2 | PF15902 | |
| Domain | VPS10 | 1.50e-03 | 5 | 232 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.50e-03 | 5 | 232 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.50e-03 | 5 | 232 | 2 | IPR031777 | |
| Domain | VPS10 | 1.50e-03 | 5 | 232 | 2 | SM00602 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.39e-07 | 11 | 180 | 5 | M47958 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 4.01e-06 | 73 | 180 | 8 | MM16641 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.91e-06 | 11 | 180 | 4 | M47370 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.96e-06 | 23 | 180 | 5 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.39e-05 | 25 | 180 | 5 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 2.01e-05 | 5 | 180 | 3 | M49016 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 3.98e-05 | 6 | 180 | 3 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 3.98e-05 | 6 | 180 | 3 | MM15273 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 4.15e-05 | 16 | 180 | 4 | M47682 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 5.37e-05 | 17 | 180 | 4 | M47684 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 5.37e-05 | 17 | 180 | 4 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 5.37e-05 | 17 | 180 | 4 | MM1408 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 2.30e-04 | 10 | 180 | 3 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 2.30e-04 | 10 | 180 | 3 | M47420 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 2.30e-04 | 10 | 180 | 3 | M47735 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 2.99e-04 | 417 | 180 | 15 | M4072 |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.13e-04 | 11 | 180 | 3 | M47371 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.13e-04 | 11 | 180 | 3 | MM14498 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 3.13e-04 | 11 | 180 | 3 | M27420 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.13e-04 | 11 | 180 | 3 | M26913 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.19e-04 | 47 | 180 | 5 | M19708 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A8 SLC13A3 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 SLC28A1 SLC33A1 | 3.58e-04 | 249 | 180 | 11 | M5988 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.59e-04 | 27 | 180 | 4 | M47755 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.14e-04 | 12 | 180 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 4.14e-04 | 12 | 180 | 3 | M47815 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 4.14e-04 | 12 | 180 | 3 | M47597 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A ATP2B3 | 4.69e-04 | 178 | 180 | 9 | M2890 |
| Pathway | KEGG_THYROID_CANCER | 4.76e-04 | 29 | 180 | 4 | M523 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 5.33e-04 | 13 | 180 | 3 | M47589 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 6.25e-04 | 82 | 180 | 6 | M27626 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 6.67e-04 | 83 | 180 | 6 | M39637 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47384 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 6.72e-04 | 14 | 180 | 3 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 6.72e-04 | 14 | 180 | 3 | MM14667 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.72e-04 | 14 | 180 | 3 | M47488 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 7.11e-04 | 84 | 180 | 6 | M27334 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 7.86e-04 | 57 | 180 | 5 | M19888 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 7.88e-04 | 33 | 180 | 4 | M39532 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 8.30e-04 | 119 | 180 | 7 | M48309 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.32e-04 | 15 | 180 | 3 | M47531 | |
| Pathway | REACTOME_RAF_ACTIVATION | 8.84e-04 | 34 | 180 | 4 | M27556 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 9.16e-04 | 121 | 180 | 7 | M39804 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A8 SLC13A3 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 SLC28A1 SLC33A1 | 9.73e-04 | 238 | 180 | 10 | MM15076 |
| Pathway | REACTOME_RAF_ACTIVATION | 9.88e-04 | 35 | 180 | 4 | MM15271 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 180 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 180 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 180 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 180 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 180 | 3 | M47801 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 1.01e-03 | 16 | 180 | 3 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 180 | 3 | M47483 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 RYR1 RYR2 ADD2 SLC9C1 ABCC2 SLC2A8 SLC13A3 ANO10 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 FURIN SLC22A2 SLC22A4 SLC28A1 ATP2B3 SLC33A1 | 1.16e-03 | 736 | 180 | 20 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.22e-03 | 17 | 180 | 3 | M47376 | |
| Pathway | WP_MAPK_SIGNALING | NF1 BRAF NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E MAP2K1 MAP2K2 | 1.25e-03 | 246 | 180 | 10 | M39597 |
| Pathway | REACTOME_SENSORY_PERCEPTION | PDE6A OR4D9 OR13G1 OR2F1 OR6M1 OR4D2 OR6J1 PLS1 CACNA1D OR8J2 OR4K2 OR4D6 OR5A1 OR4D11 OR10Z1 OR6N1 OR51L1 OR4K3 | 1.31e-03 | 636 | 180 | 18 | M41834 |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.49e-03 | 39 | 180 | 4 | M39905 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 1.58e-03 | 5 | 180 | 2 | M27345 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 1.58e-03 | 5 | 180 | 2 | MM15085 | |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 1.64e-03 | 67 | 180 | 5 | M39630 | |
| Pathway | WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING | 1.71e-03 | 19 | 180 | 3 | M39358 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.71e-03 | 19 | 180 | 3 | M47793 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 1.71e-03 | 19 | 180 | 3 | M47596 | |
| Pathway | WP_MELANOMA | 1.75e-03 | 68 | 180 | 5 | M39811 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.99e-03 | 70 | 180 | 5 | M8232 | |
| Pathway | REACTOME_BACTERIAL_INFECTION_PATHWAYS | 2.12e-03 | 71 | 180 | 5 | M48033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.15e-03 | 43 | 180 | 4 | M47669 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.25e-03 | 72 | 180 | 5 | MM14631 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | NF1 BRAF NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E MAP2K1 MAP2K2 | 2.29e-03 | 267 | 180 | 10 | M10792 |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 2.30e-03 | 21 | 180 | 3 | M47792 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 2.30e-03 | 21 | 180 | 3 | MM1464 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 2.30e-03 | 21 | 180 | 3 | M48342 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 2.35e-03 | 6 | 180 | 2 | M47762 | |
| Pathway | WP_PILOCYTIC_ASTROCYTOMA | 2.35e-03 | 6 | 180 | 2 | M39584 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 2.35e-03 | 6 | 180 | 2 | M47636 | |
| Pathway | WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS | 2.35e-03 | 6 | 180 | 2 | M48303 | |
| Pathway | REACTOME_CA2_ACTIVATED_K_CHANNELS | 2.35e-03 | 6 | 180 | 2 | MM14543 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 2.39e-03 | 73 | 180 | 5 | M321 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GAD2 DLGAP1 ARHGEF7 KCNN1 KCNN3 HTR3D CACNA1A CACNA1B CACNA1E GRIN2A SLC22A2 GABBR1 | 2.40e-03 | 411 | 180 | 13 | M735 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | GABRB1 GAD2 ARHGEF7 HTR3D CACNA1A CACNA1B CACNA1E GRIN2A SLC22A2 GABBR1 | 2.48e-03 | 270 | 180 | 10 | M15514 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.75e-10 | 38 | 238 | 8 | 30786075 | |
| Pubmed | DLGAP1 AGAP5 VPS13C SSBP1 ADD2 NF1 ARHGEF7 AP3D1 AGAP1 CACNA1E FLII TNC LARP1 GRIN2A MACF1 AGAP9 MAP2K1 GABBR1 | 1.29e-09 | 430 | 238 | 18 | 32581705 | |
| Pubmed | 1.06e-08 | 5 | 238 | 4 | 11296258 | ||
| Pubmed | 1.06e-08 | 5 | 238 | 4 | 15451373 | ||
| Pubmed | 2.74e-08 | 14 | 238 | 5 | 9373155 | ||
| Pubmed | 7.36e-08 | 7 | 238 | 4 | 31178125 | ||
| Pubmed | 1.46e-07 | 8 | 238 | 4 | 28330839 | ||
| Pubmed | 2.62e-07 | 9 | 238 | 4 | 16382099 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 25600339 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 18413255 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 38996073 | ||
| Pubmed | Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. | 3.16e-07 | 3 | 238 | 3 | 16439621 | |
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 25463315 | ||
| Pubmed | Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy. | 3.16e-07 | 3 | 238 | 3 | 18060073 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 3.16e-07 | 3 | 238 | 3 | 24523520 | |
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 27864876 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 34267336 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 3.95e-07 | 67 | 238 | 7 | 16987237 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 4.35e-07 | 10 | 238 | 4 | 20664521 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | WLS ADD2 SEMA4C FAT1 NF1 BRAF ABCC2 AGAP1 C1orf43 FERMT1 SLC39A10 SLC16A1 PLXNC1 SLC20A2 SLC22A4 STON2 PSD4 | 4.81e-07 | 569 | 238 | 17 | 30639242 |
| Pubmed | 6.28e-07 | 45 | 238 | 6 | 25979088 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 AGAP5 UBE4B NF1 DYNC1H1 AGAP1 CACNA1E NRCAM GRIN2A MACF1 AGAP9 MAP2K1 | 6.31e-07 | 281 | 238 | 12 | 28706196 |
| Pubmed | AGAP5 VPS13C PIEZO1 WASHC5 ARHGEF7 RPRD2 MED23 AGAP1 HECTD4 LARP1 SPG11 SHOC2 LRIG3 IPO13 AGAP9 EDEM1 | 8.97e-07 | 529 | 238 | 16 | 14621295 | |
| Pubmed | DLGAP1 ADD2 NF1 ARHGEF7 CACNA1A CACNA1B CACNA1E NRCAM TNC GRIN2A SLC16A1 MACF1 GABBR1 | 9.38e-07 | 347 | 238 | 13 | 17114649 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 17704260 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.26e-06 | 4 | 238 | 3 | 32616470 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 21447798 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 12482870 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 17366577 | ||
| Pubmed | Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome. | 1.26e-06 | 4 | 238 | 3 | 18042262 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 22946697 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.26e-06 | 4 | 238 | 3 | 37141091 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 22504960 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 20107185 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 20301365 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 2.03e-06 | 14 | 238 | 4 | 28724790 | |
| Pubmed | 2.75e-06 | 15 | 238 | 4 | 20188150 | ||
| Pubmed | 2.75e-06 | 15 | 238 | 4 | 24453333 | ||
| Pubmed | 3.13e-06 | 5 | 238 | 3 | 8825650 | ||
| Pubmed | 3.13e-06 | 5 | 238 | 3 | 23423222 | ||
| Pubmed | 3.13e-06 | 5 | 238 | 3 | 24746704 | ||
| Pubmed | Germline gain-of-function mutations in RAF1 cause Noonan syndrome. | 3.13e-06 | 5 | 238 | 3 | 17603482 | |
| Pubmed | DLGAP1 TCAF1 TSC2 NF1 MDN1 ARHGEF7 TAF5 DYNC1H1 CARM1 CACNA1A CACNA1E FLII SIN3B NRCAM HECTD4 GRIN2A VIRMA STON2 DZIP3 MACF1 TP53BP1 | 3.48e-06 | 963 | 238 | 21 | 28671696 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C LAMA1 TSC2 RYR1 TMEM260 SLC38A10 MYO15B MDN1 CEP95 PLS1 DYNC1H1 ADIPOR2 CARM1 SIN3B LARP1 RNF213 REV3L OR51L1 | 3.77e-06 | 736 | 238 | 18 | 29676528 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | TSC2 ADD2 AP3D1 CACNA1B CACNA1E TNC GRIN2A MACF1 FAM131B GABBR1 | 4.88e-06 | 231 | 238 | 10 | 16452087 |
| Pubmed | SOX4 SPNS1 UBE4B CHD1 TSC2 XAB2 TBC1D20 SEMA4C NF1 ARHGEF7 STRADA TMEM41B HECTD1 CARM1 SIN3B MPDU1 C1orf43 SPG11 ZSWIM6 MED13L VIRMA TRIB3 SLC16A1 SLC20A1 SLC33A1 | 5.27e-06 | 1327 | 238 | 25 | 32694731 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 5.57e-06 | 139 | 238 | 8 | 16985003 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 6.23e-06 | 6 | 238 | 3 | 12827191 | |
| Pubmed | 6.23e-06 | 6 | 238 | 3 | 9238069 | ||
| Pubmed | RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. | 6.23e-06 | 6 | 238 | 3 | 19681119 | |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 6.23e-06 | 6 | 238 | 3 | 35324301 | |
| Pubmed | Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. | 6.23e-06 | 6 | 238 | 3 | 8157000 | |
| Pubmed | 6.23e-06 | 6 | 238 | 3 | 27912827 | ||
| Pubmed | 6.41e-06 | 101 | 238 | 7 | 9872452 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 UBE4B PIEZO1 EML2 TSC2 MAST2 RYR1 GDPD5 FAT1 SLC38A10 MDN1 HECTD1 AP3D1 DYNC1H1 RIC1 FLII HECTD4 REV3L MED13L GBA2 TRIB3 FURIN | 8.52e-06 | 1105 | 238 | 22 | 35748872 |
| Pubmed | SCFD2 PDE6A SSBP1 RYR1 RYR2 NF1 MDN1 TNC MPDU1 REV3L VIRMA WDHD1 POTEJ MAP2K2 ATP2B3 DNAH11 | 9.68e-06 | 638 | 238 | 16 | 31182584 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PIEZO1 LAMA1 SLC35E1 TSC2 WLS SORT1 PCYOX1L FAT1 NF1 TMEM41B HECTD1 RNF213 SLC39A10 PLA2R1 ZDHHC6 PSMG1 FURIN IPO13 CERCAM CHSY3 EDEM1 SLC33A1 SLC37A4 | 9.86e-06 | 1201 | 238 | 23 | 35696571 |
| Pubmed | 1.07e-05 | 152 | 238 | 8 | 34299191 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 23401445 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 18424438 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 9256245 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 20302979 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 21383153 | ||
| Pubmed | MEK drives BRAF activation through allosteric control of KSR proteins. | 1.09e-05 | 7 | 238 | 3 | 29433126 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.09e-05 | 7 | 238 | 3 | 35176221 | |
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 19206169 | ||
| Pubmed | SCFD2 VPS13C SLC35E1 BCAT2 TSC2 SEMA4C WASHC5 RIC1 SPG11 SLC39A10 LRIG3 WDR6 FURIN SLC33A1 | 1.14e-05 | 504 | 238 | 14 | 34432599 | |
| Pubmed | Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo. | 1.42e-05 | 22 | 238 | 4 | 17396120 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.47e-05 | 208 | 238 | 9 | 33230847 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | AGAP5 SSBP1 MAST2 SLC38A10 NF1 MDN1 ARHGEF7 PIK3CG NFKB1 MED23 AGAP1 C1orf43 ZC3HC1 GRIN2A ANO10 GRM8 GBA2 VIRMA SLC20A2 DNAH17 TMEM37 AGAP9 MAP2K2 | 1.68e-05 | 1242 | 238 | 23 | 30973865 |
| Pubmed | Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. | 1.73e-05 | 8 | 238 | 3 | 8668348 | |
| Pubmed | 1.73e-05 | 8 | 238 | 3 | 21514245 | ||
| Pubmed | SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF. | 1.73e-05 | 8 | 238 | 3 | 36585710 | |
| Pubmed | SLC35E1 WLS SEMA4C NF1 BRAF ANO10 SLC39A10 SLC5A3 SLC16A1 WDR6 SLC20A1 MACF1 SLC33A1 | 2.30e-05 | 467 | 238 | 13 | 30194290 | |
| Pubmed | 2.58e-05 | 9 | 238 | 3 | 14966289 | ||
| Pubmed | 2.58e-05 | 9 | 238 | 3 | 24275721 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 2.58e-05 | 9 | 238 | 3 | 12640130 | |
| Pubmed | UBE4B FCHSD2 XPO5 DYNC1H1 NRCAM ZSWIM6 SLC39A10 MED13L VIRMA LRIG3 DZIP3 MACF1 | 2.73e-05 | 407 | 238 | 12 | 12693553 | |
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 2.87e-05 | 86 | 238 | 6 | 10862698 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 3.01e-05 | 128 | 238 | 7 | 19058789 | |
| Pubmed | 3.07e-05 | 87 | 238 | 6 | 17979178 | ||
| Pubmed | 3.33e-05 | 130 | 238 | 7 | 12421765 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | TSC2 GHRHR BRAF PIK3CG NFKB1 ABCC2 ASCC3 TNC RET REV3L TP53BP1 | 3.40e-05 | 351 | 238 | 11 | 20453000 |
| Pubmed | 3.66e-05 | 10 | 238 | 3 | 11579140 | ||
| Pubmed | Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. | 3.66e-05 | 10 | 238 | 3 | 12167619 | |
| Pubmed | 3.66e-05 | 10 | 238 | 3 | 18952847 | ||
| Pubmed | TCAF1 CTIF SEMA4C MYO15B TMEM41B HECTD1 RIC1 PRUNE2 SIN3B RNF213 GBA2 DNAH17 MACF1 | 4.02e-05 | 493 | 238 | 13 | 15368895 | |
| Pubmed | GABRB1 SSBP1 SORT1 XPO5 ANKMY2 HAX1 HECTD1 CARM1 WDR6 DNAH17 EDRF1 | 4.61e-05 | 363 | 238 | 11 | 25036637 | |
| Pubmed | Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. | 4.66e-05 | 2 | 238 | 2 | 9563949 | |
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 15143067 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 23968976 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 17464312 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 12832465 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 20139130 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 21705440 | ||
| Pubmed | High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma. | 4.66e-05 | 2 | 238 | 2 | 19147753 | |
| Pubmed | 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. | 4.66e-05 | 2 | 238 | 2 | 17356845 | |
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 19427341 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 12205090 | ||
| Pubmed | 4.66e-05 | 2 | 238 | 2 | 20840674 | ||
| Interaction | SORCS1 interactions | 5.44e-07 | 7 | 228 | 4 | int:SORCS1 | |
| Interaction | GPR182 interactions | SPNS1 TCAF1 SLC35E1 TSC2 WLS MDN1 XPO5 WASHC5 MED23 TMEM184B RNF213 SPG11 SLC39A10 NR2F1 SLC5A3 LIPE OXA1L IPO13 SLC33A1 | 1.13e-06 | 455 | 228 | 19 | int:GPR182 |
| Interaction | CACNA1D interactions | 6.33e-06 | 24 | 228 | 5 | int:CACNA1D | |
| Interaction | HLA-B interactions | SPNS1 SLC35E1 MDN1 WASHC5 MED23 SH2D3C RNF213 SLC39A10 TRIB3 SLC20A1 IPO13 EDEM1 | 1.89e-05 | 239 | 228 | 12 | int:HLA-B |
| Interaction | HCST interactions | CTU2 TSC2 NF1 MDN1 XPO5 TMEM184B RNF213 SPG11 SLC39A10 NR2F1 IPO13 | 2.29e-05 | 205 | 228 | 11 | int:HCST |
| GeneFamily | Solute carriers | SLC35E1 SLC22A24 SLC9C1 SLC38A10 SLC2A8 SLC13A3 SLC39A10 SLC5A3 SLC16A1 SLC20A1 SLC20A2 SLC22A2 SLC22A4 SLC28A1 SLC33A1 SLC37A4 | 6.99e-07 | 395 | 165 | 16 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 3.36e-06 | 26 | 165 | 5 | 253 | |
| GeneFamily | Dyneins, axonemal | 1.45e-05 | 17 | 165 | 4 | 536 | |
| GeneFamily | Cadherin related | 1.45e-05 | 17 | 165 | 4 | 24 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.47e-04 | 3 | 165 | 2 | 287 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 4.62e-04 | 17 | 165 | 3 | 1291 | |
| GeneFamily | Olfactory receptors, family 4 | 1.19e-03 | 129 | 165 | 6 | 151 | |
| GeneFamily | Potassium calcium-activated channels | 1.21e-03 | 6 | 165 | 2 | 255 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 1.69e-03 | 7 | 165 | 2 | 653 | |
| GeneFamily | U-box domain containing | 1.69e-03 | 7 | 165 | 2 | 365 | |
| GeneFamily | Ankyrin repeat domain containing | 1.74e-03 | 242 | 165 | 8 | 403 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.86e-03 | 9 | 165 | 2 | 973 | |
| GeneFamily | ArfGAPs | 3.33e-03 | 33 | 165 | 3 | 395 | |
| GeneFamily | LIM class homeoboxes | 5.15e-03 | 12 | 165 | 2 | 522 | |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 9.60e-06 | 154 | 231 | 9 | M39034 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS | 2.32e-05 | 172 | 231 | 9 | M40263 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 2.47e-05 | 97 | 231 | 7 | M14698 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CHD1 CTIF MAST2 FCHSD2 FAT1 MDN1 ARHGEF7 NFKB1 ANKMY2 ASCC3 AGAP1 SPG11 STAM REV3L MED13L SHOC2 WDHD1 SLC20A2 MACF1 MAP2K1 TP53BP1 | 2.54e-05 | 856 | 231 | 21 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.32e-05 | 180 | 231 | 9 | M8239 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 PKD1L2 FREM1 RYR2 SORCS1 FAT1 DNAH5 NRCAM FAT3 ROS1 MYO16 DNAH11 | 3.23e-10 | 184 | 236 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 PKD1L2 FREM1 RYR2 SORCS1 FAT1 DNAH5 NRCAM FAT3 ROS1 MYO16 DNAH11 | 3.23e-10 | 184 | 236 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 PKD1L2 FREM1 RYR2 SORCS1 FAT1 DNAH5 NRCAM FAT3 ROS1 MYO16 DNAH11 | 3.23e-10 | 184 | 236 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK2 ABCA1 VPS13C SLC38A10 ASCC3 DYNC1H1 CACNA1A CACNA1D TMPRSS6 RET REV3L MACF1 | 6.29e-10 | 195 | 236 | 12 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK2 ABCA1 VPS13C SLC38A10 ASCC3 DYNC1H1 CACNA1A CACNA1D TMPRSS6 RET REV3L MACF1 | 6.29e-10 | 195 | 236 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 LAMA1 SVEP1 FREM1 RYR2 CACNA1D NRCAM TNC REV3L NR2F1 MACF1 MYO16 | 7.94e-10 | 199 | 236 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | VPS13C CHD1 NF1 BRAF NFKB1 DYNC1H1 RNF213 MED13L SLC20A1 MACF1 TP53BP1 | 5.59e-09 | 188 | 236 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 LAMA1 SVEP1 FREM1 RYR2 CACNA1D TNC REV3L NR2F1 MACF1 MYO16 | 1.06e-08 | 200 | 236 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC22A24 ABCC2 PLS1 AGAP1 PRUNE2 SLC13A3 CLDN10 SLC22A2 SLC22A4 SLC28A1 | 6.22e-08 | 186 | 236 | 10 | b1edc341d6684b347dc9e21b34f62f51d095d735 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-08 | 189 | 236 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | DLGAP1 CLSTN2 FAT1 ABCC2 AGAP1 PRUNE2 SLC13A3 CLDN10 SLC22A2 SLC28A1 | 7.22e-08 | 189 | 236 | 10 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-08 | 191 | 236 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.37e-08 | 192 | 236 | 10 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.37e-08 | 192 | 236 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-08 | 145 | 236 | 9 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-07 | 197 | 236 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.23e-07 | 200 | 236 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | RYR1 SORCS1 KCNN1 NLRP5 CACNA1A CACNA1B CACNA1E SLC13A3 SLC28A1 | 2.81e-07 | 167 | 236 | 9 | 3edb0570e583bb527165bcd8a4c25a042054043b |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | SLC22A24 SORCS1 ABCC2 PRUNE2 CACNA1E SLC13A3 CLDN10 SLC22A2 SLC28A1 | 4.82e-07 | 178 | 236 | 9 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | DLGAP1 FAT1 ABCC2 PRUNE2 CACNA1E SLC13A3 CLDN10 SLC22A2 SLC28A1 | 5.29e-07 | 180 | 236 | 9 | 864c895b5eaedefae86f5829fa344f7b686fb59f |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.54e-07 | 181 | 236 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | SLC22A24 FAT1 ABCC2 PRUNE2 NRCAM SLC13A3 CLDN10 SLC22A2 SLC28A1 | 6.08e-07 | 183 | 236 | 9 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 184 | 236 | 9 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | DLGAP1 FAT1 ABCC2 AGAP1 PRUNE2 SLC13A3 CLDN10 SLC22A2 SLC28A1 | 7.28e-07 | 187 | 236 | 9 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.28e-07 | 187 | 236 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | DLGAP1 CLSTN2 FAT1 AGAP1 PRUNE2 CLDN10 SLC22A2 STON2 SLC28A1 | 7.28e-07 | 187 | 236 | 9 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.28e-07 | 187 | 236 | 9 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | DLGAP1 CLSTN2 SORCS1 ABCC2 PRUNE2 SLC13A3 CLDN10 SLC22A2 SLC28A1 | 7.96e-07 | 189 | 236 | 9 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-07 | 189 | 236 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | DLGAP1 CLSTN2 SORCS1 ABCC2 PRUNE2 SLC13A3 CLDN10 SLC22A2 SLC28A1 | 7.96e-07 | 189 | 236 | 9 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.47e-07 | 193 | 236 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-07 | 193 | 236 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.47e-07 | 193 | 236 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-07 | 194 | 236 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.89e-07 | 194 | 236 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-07 | 194 | 236 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.12e-06 | 197 | 236 | 9 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.17e-06 | 198 | 236 | 9 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 236 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-06 | 158 | 236 | 8 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 160 | 236 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 160 | 236 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 161 | 236 | 8 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 161 | 236 | 8 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.40e-06 | 161 | 236 | 8 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-06 | 162 | 236 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-06 | 170 | 236 | 8 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.59e-06 | 170 | 236 | 8 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 3.59e-06 | 170 | 236 | 8 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-06 | 175 | 236 | 8 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Chrna6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.71e-06 | 125 | 236 | 7 | fac8a9bff83abb8976013ff7d2b4ce0b68fbb70a | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.48e-06 | 180 | 236 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.48e-06 | 180 | 236 | 8 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.48e-06 | 180 | 236 | 8 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-06 | 181 | 236 | 8 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.70e-06 | 181 | 236 | 8 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.70e-06 | 181 | 236 | 8 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 6.43e-06 | 184 | 236 | 8 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.43e-06 | 184 | 236 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.43e-06 | 184 | 236 | 8 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 185 | 236 | 8 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 185 | 236 | 8 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 185 | 236 | 8 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.53e-06 | 188 | 236 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-06 | 190 | 236 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-06 | 190 | 236 | 8 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 191 | 236 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 191 | 236 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.46e-06 | 191 | 236 | 8 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.46e-06 | 191 | 236 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.78e-06 | 192 | 236 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.12e-06 | 193 | 236 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.12e-06 | 193 | 236 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-06 | 194 | 236 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-06 | 194 | 236 | 8 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.47e-06 | 194 | 236 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 9.47e-06 | 194 | 236 | 8 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-05 | 196 | 236 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 196 | 236 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-05 | 142 | 236 | 7 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-05 | 198 | 236 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 198 | 236 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 198 | 236 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 198 | 236 | 8 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-05 | 199 | 236 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-05 | 199 | 236 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.14e-05 | 199 | 236 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 236 | 8 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 236 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 236 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.18e-05 | 200 | 236 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 236 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-05 | 200 | 236 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 236 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Drug | isradipine | GAD2 GCG ACE RYR1 RYR2 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 5.21e-10 | 100 | 235 | 12 | CID000003784 |
| Drug | AC1L2AC7 | ACE RYR1 RYR2 NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 2.26e-09 | 69 | 235 | 10 | CID000068733 |
| Drug | Cinildipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 5.67e-09 | 56 | 235 | 9 | CID000002752 |
| Drug | nilvadipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 1.07e-08 | 60 | 235 | 9 | CID000004494 |
| Drug | lercanidipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 1.66e-08 | 63 | 235 | 9 | CID000065866 |
| Drug | mibefradil | 1.92e-08 | 64 | 235 | 9 | CID000060662 | |
| Drug | gabapentin | GABRB1 BCAT2 RYR1 RYR2 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 TMEM37 | 2.40e-08 | 169 | 235 | 13 | CID000003446 |
| Drug | riluzole | GABRB1 RYR1 RYR2 SCN7A KCNN1 KCNN3 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 | 3.40e-08 | 174 | 235 | 13 | CID000005070 |
| Drug | CNS 1145 | 3.88e-08 | 33 | 235 | 7 | CID000190902 | |
| Drug | IHC-64 | 3.88e-08 | 33 | 235 | 7 | CID000162753 | |
| Drug | manidipine | ACTL6A ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 5.32e-08 | 95 | 235 | 10 | CID000004008 |
| Drug | CAS 298-57-7 | RYR1 RYR2 CACNA1I PLS1 CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 6.24e-08 | 73 | 235 | 9 | CID000002761 |
| Drug | nisoldipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 1.12e-07 | 78 | 235 | 9 | CID000004499 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.25e-07 | 79 | 235 | 9 | CID005287890 | |
| Drug | 3,4-dihydroquinazoline | 1.63e-07 | 6 | 235 | 4 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 1.63e-07 | 6 | 235 | 4 | CID000133976 | |
| Drug | mercury | GCG CLSTN2 ACE RYR1 RYR2 PIK3CG NFKB1 CACNA1I ABCC2 MED23 CARM1 CACNA1A CACNA1B CACNA1D CACNA1E SLC13A3 GBA2 FURIN GSTCD MAP2K2 ATP2B3 | 2.38e-07 | 542 | 235 | 21 | CID000023931 |
| Drug | nimodipine | RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 TMEM37 ATP2B3 | 3.37e-07 | 145 | 235 | 11 | CID000004497 |
| Drug | Dantrolene-13C3 | RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 LIPE TMEM37 | 3.37e-07 | 145 | 235 | 11 | CID000002951 |
| Drug | lamotrigine | RYR1 RYR2 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A TMEM37 | 3.55e-07 | 116 | 235 | 10 | CID000003878 |
| Drug | AC1NBU2S | RYR1 RYR2 BRAF NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E MAP2K1 | 3.85e-07 | 117 | 235 | 10 | CID004473765 |
| Drug | gallopamil | 4.41e-07 | 67 | 235 | 8 | CID000001234 | |
| Drug | baclofen | GABRB1 GAD2 RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 GABBR1 | 7.51e-07 | 191 | 235 | 12 | CID000002284 |
| Drug | bepridil | RYR1 RYR2 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TNC TMEM37 | 7.67e-07 | 126 | 235 | 10 | CID000002351 |
| Drug | nitrendipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 8.09e-07 | 98 | 235 | 9 | CID000004507 |
| Drug | ethosuximide | 9.59e-07 | 74 | 235 | 8 | CID000003291 | |
| Drug | loperamide | RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A TMEM37 | 1.45e-06 | 105 | 235 | 9 | CID000003954 |
| Drug | lanthanum | RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GSTCD TMEM37 ATP2B3 | 1.55e-06 | 136 | 235 | 10 | CID000023926 |
| Drug | lavendustin A | RYR1 RYR2 PIK3CG CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A MAP2K1 MAP2K2 | 1.74e-06 | 171 | 235 | 11 | CID000003894 |
| Drug | isovalerate | MGAT4A LAMA1 BCAT2 RYR1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 2.44e-06 | 143 | 235 | 10 | CID000010430 |
| Drug | tetradotoxin | GABRB1 GAD2 GCG SORT1 FAT1 SCN7A KCNN1 KCNN3 SCT CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 OXA1L | 2.49e-06 | 428 | 235 | 17 | CID000020382 |
| Drug | AC1L1DXE | CLSTN2 ACTL6A RYR1 RYR2 SORT1 PIK3CG NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E FLII GRIN2A | 3.03e-06 | 299 | 235 | 14 | CID000002548 |
| Drug | IAA-94 | 3.10e-06 | 61 | 235 | 7 | CID000003667 | |
| Drug | Bay K 8644 | RYR1 RYR2 NF1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 ATP2B3 | 3.76e-06 | 150 | 235 | 10 | CID000002303 |
| Drug | Biliton | 3.77e-06 | 41 | 235 | 6 | CID000002974 | |
| Drug | AC 110 | 4.31e-06 | 4 | 235 | 3 | CID000022860 | |
| Drug | procaine | GCG RYR1 RYR2 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 4.48e-06 | 153 | 235 | 10 | CID000004914 |
| Drug | AC1L2VU3 | 5.13e-06 | 12 | 235 | 4 | CID000129572 | |
| Drug | gadolinium | GALC RYR1 RYR2 GHRHR NF1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E SLC33A1 | 7.50e-06 | 199 | 235 | 11 | CID000023982 |
| Drug | PD184352 | 7.52e-06 | 46 | 235 | 6 | CID006918454 | |
| Drug | mAHP | 7.53e-06 | 27 | 235 | 5 | CID000220531 | |
| Drug | 2-chloropropionate | 7.53e-06 | 27 | 235 | 5 | CID000011734 | |
| Drug | indo-1 | 8.73e-06 | 99 | 235 | 8 | CID000105060 | |
| Drug | AC1L1IZE | 9.05e-06 | 131 | 235 | 9 | CID000004799 | |
| Drug | Pilocarpine | GAD2 KCNN1 KCNN3 ABCC2 CACNA1A CACNA1B CACNA1D TNC GRIN2A RET GRM8 SLC5A3 SLC22A2 | 9.08e-06 | 285 | 235 | 13 | ctd:D010862 |
| Drug | almagel | 1.07e-05 | 5 | 235 | 3 | CID003080942 | |
| Drug | AC1L1KS5 | GCG RYR1 RYR2 SORT1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRM8 PLCXD3 MAP2K1 MAP2K2 ATP2B3 | 1.07e-05 | 334 | 235 | 14 | CID000005631 |
| Drug | felodipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 SLC33A1 | 1.08e-05 | 169 | 235 | 10 | CID000003333 |
| Drug | Diazepam | 1.14e-05 | 74 | 235 | 7 | ctd:D003975 | |
| Drug | BAPTA-AM | ACTL6A RYR1 FAT1 NFKB1 KCNN1 KCNN3 SCT CACNA1A CACNA1B CACNA1D GRIN2A GRM8 EDEM1 | 1.22e-05 | 293 | 235 | 13 | CID000002293 |
| Drug | butamben | 1.38e-05 | 15 | 235 | 4 | CID000002482 | |
| Drug | N-methyl-DL-aspartic acid | GABRB1 GAD2 DLGAP1 SPNS1 RYR1 RYR2 SORT1 FAT1 NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E FLII GRIN2A ZSWIM6 GRM8 TMEM37 MAP2K1 | 1.67e-05 | 655 | 235 | 20 | CID000004376 |
| Drug | phlorizine | 1.76e-05 | 79 | 235 | 7 | CID000004789 | |
| Drug | pentasulfane | 1.83e-05 | 16 | 235 | 4 | CID000448216 | |
| Drug | Verapamil | 1.83e-05 | 16 | 235 | 4 | DB00661 | |
| Drug | phenytoin | RYR1 RYR2 NFKB1 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E LIPE TMEM37 | 1.84e-05 | 219 | 235 | 11 | CID000001775 |
| Drug | nicardipine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 2.05e-05 | 145 | 235 | 9 | CID000004473 |
| Drug | NSC7524 | GAD2 RYR1 RYR2 SCN7A CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A | 2.06e-05 | 182 | 235 | 10 | CID000005657 |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | GCG ACTL6A RYR1 RYR2 PIK3CG SCT CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E MAP2K1 MAP2K2 | 2.06e-05 | 308 | 235 | 13 | CID000001915 |
| Drug | caffeine | PDE6A RYR1 RYR2 CDC7 CACNA1I PLS1 CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 GBA2 LIPE OXA1L TMEM37 PLCXD3 ATP2B3 | 2.39e-05 | 562 | 235 | 18 | CID000002519 |
| Drug | Aliquat 336 | 2.45e-05 | 34 | 235 | 5 | CID000021218 | |
| Drug | XeC compound | 2.63e-05 | 84 | 235 | 7 | CID000005701 | |
| Drug | NSC759576 | ACE RYR1 RYR2 NFKB1 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 | 3.12e-05 | 191 | 235 | 10 | CID000003075 |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.12e-05 | 191 | 235 | 10 | 3861_UP | |
| Drug | lindane | 3.30e-05 | 154 | 235 | 9 | CID000000727 | |
| Drug | dihydropyridine | ACE RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E TMEM37 ATP2B3 | 3.40e-05 | 193 | 235 | 10 | CID000104822 |
| Drug | BAPTA | RYR1 RYR2 NFKB1 CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 EDEM1 MAP2K1 MAP2K2 ATP2B3 | 3.50e-05 | 324 | 235 | 13 | CID000104751 |
| Drug | APMPA | 3.69e-05 | 7 | 235 | 3 | CID000512300 | |
| Drug | butylparaben | GABRB1 TSC2 NF1 CACNA1I CACNA1A CACNA1D CACNA1E NRCAM SLC22A2 | 3.84e-05 | 157 | 235 | 9 | ctd:C038091 |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; HL60; HT_HG-U133A | 4.23e-05 | 198 | 235 | 10 | 1326_DN | |
| Drug | isobutanol | 4.30e-05 | 62 | 235 | 6 | CID000006560 | |
| Drug | C070379 | RYR1 RYR2 NFKB1 CACNA1B CACNA1E GRIN2A GRM8 MAP2K1 MAP2K2 ATP2B3 | 4.41e-05 | 199 | 235 | 10 | CID003034747 |
| Drug | Baclofen | 4.71e-05 | 20 | 235 | 4 | ctd:D001418 | |
| Drug | AC1NUZ8M | 4.75e-05 | 92 | 235 | 7 | CID000073211 | |
| Drug | potassium | UBE4B GCG ACE RYR1 RYR2 PIK3CG NFKB1 SCN7A KCNN1 KCNN3 SCT CACNA1I MED23 CACNA1A CACNA1B CACNA1D CACNA1E GRIN2A GRM8 PLA2R1 FURIN TMEM37 PLCXD3 ATP2B3 SLC33A1 | 4.85e-05 | 1008 | 235 | 25 | CID000000813 |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 4.85e-05 | 39 | 235 | 5 | CID003331970 | |
| Drug | AC1L1KC5 | GPR85 ACTL6A RYR1 RYR2 KCNN1 SCT CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E GRM8 TRIB3 TMEM37 EDEM1 MAP2K1 ATP2B3 | 5.12e-05 | 541 | 235 | 17 | CID000005428 |
| Drug | pimozide | 5.34e-05 | 127 | 235 | 8 | CID000016362 | |
| Drug | verapamil | ABCA1 ACE RYR1 RYR2 SCN7A KCNN1 KCNN3 CACNA1I ABCC2 CACNA1A CACNA1B CACNA1D CACNA1E SLC22A4 TMEM37 ATP2B3 | 5.44e-05 | 490 | 235 | 16 | CID000002520 |
| Drug | Linuron | 5.64e-05 | 128 | 235 | 8 | ctd:D008044 | |
| Drug | polyethylenimine | 5.64e-05 | 128 | 235 | 8 | CID000009033 | |
| Drug | Calcium | GCG RYR1 RYR2 NF1 KCNN3 SCT CACNA1I ABCC2 CACNA1A CACNA1B CACNA1D CACNA1E FURIN MAP2K1 MAP2K2 GABBR1 | 5.84e-05 | 493 | 235 | 16 | ctd:D002118 |
| Drug | enzacamene | 5.96e-05 | 129 | 235 | 8 | ctd:C038939 | |
| Drug | isotetrandrine | 6.66e-05 | 97 | 235 | 7 | CID000005422 | |
| Drug | DCG-IV | 7.28e-05 | 68 | 235 | 6 | CID000115114 | |
| Drug | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | 8.16e-05 | 173 | 235 | 9 | ctd:C063509 | |
| Drug | Foscarnet | 8.71e-05 | 9 | 235 | 3 | ctd:D017245 | |
| Drug | VPA-G | 8.71e-05 | 9 | 235 | 3 | CID000088111 | |
| Drug | AC1L1JI6 | 8.71e-05 | 9 | 235 | 3 | CID000005051 | |
| Drug | papaverine | PDE6A RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E PLCXD3 | 9.30e-05 | 176 | 235 | 9 | CID000004680 |
| Drug | phenoxyacetate | 9.99e-05 | 24 | 235 | 4 | CID000019188 | |
| Drug | octylmethoxycinnamate | 1.01e-04 | 139 | 235 | 8 | ctd:C118580 | |
| Drug | TAK 733 | 1.06e-04 | 2 | 235 | 2 | ctd:C558666 | |
| Drug | dysprosium oxide | 1.06e-04 | 2 | 235 | 2 | CID000159370 | |
| Drug | aristolactam AII | 1.06e-04 | 2 | 235 | 2 | CID000148657 | |
| Drug | alkosin | 1.06e-04 | 2 | 235 | 2 | CID005488638 | |
| Drug | norcepharadione B | 1.06e-04 | 2 | 235 | 2 | CID000189168 | |
| Drug | piperolactam A | 1.06e-04 | 2 | 235 | 2 | CID003081016 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 1.06e-04 | 2 | 235 | 2 | ctd:C544830 | |
| Drug | halothane | GABRB1 RYR1 RYR2 CACNA1I CACNA1A CACNA1B CACNA1D CACNA1E LIPE TMEM37 PLCXD3 ATP2B3 | 1.11e-04 | 314 | 235 | 12 | CID000003562 |
| Disease | Autistic Disorder | GABRB1 TSC2 ACE NF1 PIK3CG SCN7A SCT AGAP1 NRCAM GRIN2A GRM8 ASMT GABBR1 | 1.57e-07 | 261 | 230 | 13 | C0004352 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 4.67e-07 | 3 | 230 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | GAD2 SCN7A DYNC1H1 CACNA1A CACNA1B CACNA1E NRCAM SLC13A3 GRIN2A GRM8 | 6.63e-07 | 163 | 230 | 10 | DOID:1826 (implicated_via_orthology) |
| Disease | cerebral palsy (implicated_via_orthology) | 7.28e-07 | 10 | 230 | 4 | DOID:1969 (implicated_via_orthology) | |
| Disease | Noonan Syndrome | 1.04e-06 | 24 | 230 | 5 | C0028326 | |
| Disease | Noonan Syndrome 1 | 1.14e-06 | 11 | 230 | 4 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.14e-06 | 11 | 230 | 4 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.14e-06 | 11 | 230 | 4 | C1527404 | |
| Disease | migraine (implicated_via_orthology) | 1.86e-06 | 4 | 230 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | PCSK2 ABCA1 LAMA1 OTOP2 EML2 CHD1 CLSTN2 GHRHR FAT1 NF1 BRAF ABCC2 DNAH8 NRCAM GRIN2A RET STAM SLC33A1 EDRF1 | 2.96e-06 | 702 | 230 | 19 | C0009402 |
| Disease | RASopathy | 4.59e-06 | 15 | 230 | 4 | cv:C5555857 | |
| Disease | Seizures | GAD2 GALC TSC2 TBC1D20 ABCC2 AP3D1 CACNA1B CACNA1E MPDU1 MACF1 | 8.99e-06 | 218 | 230 | 10 | C0036572 |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.27e-05 | 19 | 230 | 4 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.27e-05 | 19 | 230 | 4 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.27e-05 | 19 | 230 | 4 | C1275081 | |
| Disease | Costello syndrome (disorder) | 1.27e-05 | 19 | 230 | 4 | C0587248 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.60e-05 | 7 | 230 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Cutaneous Melanoma | 1.64e-05 | 41 | 230 | 5 | C0151779 | |
| Disease | LEOPARD Syndrome | 2.36e-05 | 22 | 230 | 4 | C0175704 | |
| Disease | RASopathy (implicated_via_orthology) | 3.79e-05 | 9 | 230 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Hodgkins lymphoma | 4.49e-05 | 82 | 230 | 6 | EFO_0000183 | |
| Disease | thalamus volume | 5.50e-05 | 85 | 230 | 6 | EFO_0006935 | |
| Disease | cardiofaciocutaneous syndrome (implicated_via_orthology) | 6.05e-05 | 2 | 230 | 2 | DOID:0060233 (implicated_via_orthology) | |
| Disease | Neurofibromatosis-Noonan syndrome | 6.05e-05 | 2 | 230 | 2 | C2931482 | |
| Disease | Hairy Cell Leukemia | 6.05e-05 | 2 | 230 | 2 | C0023443 | |
| Disease | Alzheimer disease, polygenic risk score | BCAT2 MAST2 ACE ILRUN CACNA1E SPG11 ZSWIM6 RET GRM8 WDPCP PLA2R1 MKX PLCXD3 CHSY3 GABBR1 | 6.29e-05 | 586 | 230 | 15 | EFO_0030082, MONDO_0004975 |
| Disease | Bipolar Disorder | GABRB1 GAD2 ACE CNTN6 KCNN3 DNAH8 CACNA1A CACNA1B CACNA1D GRIN2A SLC5A3 ASMT PLCXD3 | 1.05e-04 | 477 | 230 | 13 | C0005586 |
| Disease | melanoma | 1.53e-04 | 248 | 230 | 9 | C0025202 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.80e-04 | 67 | 230 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | NOONAN SYNDROME 1 | 1.81e-04 | 3 | 230 | 2 | 163950 | |
| Disease | Cafe-au-lait macules with pulmonary stenosis | 1.81e-04 | 3 | 230 | 2 | C0553586 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.81e-04 | 3 | 230 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.81e-04 | 3 | 230 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Noonan syndrome 1 | 1.81e-04 | 3 | 230 | 2 | cv:C4551602 | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 1.81e-04 | 3 | 230 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | bilirubin measurement | HLA-DQB2 HLA-DRA PIEZO1 PKD1L2 ARHGEF7 ABCC2 TMPRSS6 REV3L OR10Z1 PLA2R1 SLC22A4 DNAH11 | 2.00e-04 | 442 | 230 | 12 | EFO_0004570 |
| Disease | C-reactive protein measurement | ABCA1 UBE4B VPS13C HLA-DQB2 HLA-DRA HLX EML2 BCAT2 NYNRIN NFKB1 KCNN3 HAX1 CARM1 ILRUN SPG11 DNAH17 RAVER2 MACF1 THNSL2 TP53BP1 DNAH11 PSD4 | 2.06e-04 | 1206 | 230 | 22 | EFO_0004458 |
| Disease | Intellectual Disability | SOX4 LAMA1 ACTL6A TBC1D20 NF1 ASCC3 MED23 DYNC1H1 CACNA1B CACNA1E MED13L MACF1 | 2.22e-04 | 447 | 230 | 12 | C3714756 |
| Disease | Ciliopathies | 2.29e-04 | 110 | 230 | 6 | C4277690 | |
| Disease | Alcoholic Intoxication, Chronic | 2.73e-04 | 268 | 230 | 9 | C0001973 | |
| Disease | autistic disorder (is_implicated_in) | 3.19e-04 | 42 | 230 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 3.47e-04 | 277 | 230 | 9 | C0009404 | |
| Disease | Tachycardia | 3.50e-04 | 18 | 230 | 3 | C0039231 | |
| Disease | Tachyarrhythmia | 3.50e-04 | 18 | 230 | 3 | C0080203 | |
| Disease | Melanocytic nevus | 3.59e-04 | 4 | 230 | 2 | C0027962 | |
| Disease | Kartagener syndrome (is_implicated_in) | 3.59e-04 | 4 | 230 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | schizophrenia (is_implicated_in) | 3.66e-04 | 78 | 230 | 5 | DOID:5419 (is_implicated_in) | |
| Disease | Manic | 3.66e-04 | 78 | 230 | 5 | C0338831 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.83e-04 | 121 | 230 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 4.96e-04 | 127 | 230 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | reticulocyte count | GAD2 ABCA1 PIEZO1 CTIF MAST2 FAT1 NFKB1 HAX1 PLS1 TMPRSS6 HECTD4 LARP1 DCUN1D1 SLC22A4 DNAH17 DZIP3 ADGRD2 HBM WDSUB1 | 5.84e-04 | 1045 | 230 | 19 | EFO_0007986 |
| Disease | tuberous sclerosis (implicated_via_orthology) | 5.96e-04 | 5 | 230 | 2 | DOID:13515 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of thyroid | 5.96e-04 | 5 | 230 | 2 | C0007115 | |
| Disease | Combined pituitary hormone deficiencies, genetic form | 5.96e-04 | 5 | 230 | 2 | cv:C4273747 | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 5.96e-04 | 5 | 230 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Congenital absence of kidneys syndrome | 5.96e-04 | 5 | 230 | 2 | C1609433 | |
| Disease | eosinophil count | GAD2 HLA-DQB2 HLA-DRA SLC35E1 HLX CHD1 SVEP1 CDC7 SLC9C1 MDN1 NFKB1 QPCT FERMT1 HECTD4 ZC3HC1 PLA2R1 TRIB3 PLXNC1 WDR6 RAVER2 MAP2K2 MYO16 GABBR1 TP53BP1 | 6.32e-04 | 1488 | 230 | 24 | EFO_0004842 |
| Disease | cholangiocarcinoma (is_implicated_in) | 6.45e-04 | 22 | 230 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | diabetic retinopathy | 7.11e-04 | 136 | 230 | 6 | EFO_0003770 | |
| Disease | glycine measurement | 7.39e-04 | 137 | 230 | 6 | EFO_0009767 | |
| Disease | neuroimaging measurement | SCFD2 HLA-DQB2 LRRC49 EML2 WLS NF1 LRRIQ1 AGAP1 FAT3 MPDU1 SLC13A3 STAM REV3L FURIN MKX MACF1 MYO16 GABBR1 DNAH11 | 7.66e-04 | 1069 | 230 | 19 | EFO_0004346 |
| Disease | osteoarthritis, hip | 7.81e-04 | 92 | 230 | 5 | EFO_1000786 | |
| Disease | Coronary heart disease | 8.38e-04 | 24 | 230 | 3 | C0010068 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.83e-04 | 195 | 230 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Conn Syndrome | 8.89e-04 | 6 | 230 | 2 | C1384514 | |
| Disease | Varicosity | 8.89e-04 | 6 | 230 | 2 | C0042345 | |
| Disease | Leopard Syndrome 1 | 8.89e-04 | 6 | 230 | 2 | C4551484 | |
| Disease | Hyperaldosteronism | 8.89e-04 | 6 | 230 | 2 | C0020428 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.58e-04 | 144 | 230 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | ergothioneine measurement | 1.06e-03 | 26 | 230 | 3 | EFO_0021163 | |
| Disease | myeloid white cell count | SCFD2 GAD2 PIEZO1 HLX CTIF MAST2 STRADA NFKB1 HTR3D PRUNE2 HECTD4 ZC3HC1 PLA2R1 FURIN SLC22A4 ADGRD2 MAP2K2 | 1.16e-03 | 937 | 230 | 17 | EFO_0007988 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.18e-03 | 150 | 230 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | panhypopituitarism (is_implicated_in) | 1.24e-03 | 7 | 230 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | arabinose measurement | 1.24e-03 | 7 | 230 | 2 | EFO_0021030 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.45e-03 | 156 | 230 | 6 | C0007131 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.60e-03 | 108 | 230 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | melanoma (implicated_via_orthology) | 1.64e-03 | 8 | 230 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 1.64e-03 | 8 | 230 | 2 | C0266294 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.64e-03 | 8 | 230 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin concentration | 1.64e-03 | 8 | 230 | 2 | EFO_0004509, EFO_0004528 | |
| Disease | Coronary Artery Disease | 1.68e-03 | 65 | 230 | 4 | C1956346 | |
| Disease | Coronary Arteriosclerosis | 1.68e-03 | 65 | 230 | 4 | C0010054 | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 1.79e-03 | 31 | 230 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | Noonan syndrome | 2.10e-03 | 9 | 230 | 2 | cv:C0028326 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 2.15e-03 | 33 | 230 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Nonalcoholic Steatohepatitis | 2.20e-03 | 70 | 230 | 4 | C3241937 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.20e-03 | 70 | 230 | 4 | C0400966 | |
| Disease | Manic Disorder | 2.32e-03 | 71 | 230 | 4 | C0024713 | |
| Disease | bullous pemphigoid | 2.34e-03 | 34 | 230 | 3 | EFO_0007187 | |
| Disease | visual epilepsy (implicated_via_orthology) | 2.34e-03 | 34 | 230 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 2.34e-03 | 34 | 230 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.34e-03 | 34 | 230 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.34e-03 | 34 | 230 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.34e-03 | 34 | 230 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.34e-03 | 34 | 230 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.34e-03 | 34 | 230 | 3 | C0087012 | |
| Disease | chronic lymphocytic leukemia | 2.45e-03 | 119 | 230 | 5 | EFO_0000095 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.54e-03 | 120 | 230 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 2.55e-03 | 35 | 230 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.55e-03 | 35 | 230 | 3 | C0752122 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAWEADLAMDSTFQL | 721 | Q5DID0 | |
| ATQDIAVDGWALTML | 191 | O00400 | |
| AIMTVFQILTGEDWN | 656 | O00555 | |
| NTALSAELMWAEGRF | 96 | Q6XXX2 | |
| GSHQFEQLSGSILWM | 606 | P15056 | |
| EWTDAVQLTALVMGS | 111 | Q9NSK7 | |
| VMSSIGNELANSVWE | 676 | Q9UPQ3 | |
| VMSSIGNELANSIWE | 576 | Q5VTM2 | |
| SLDMLGTDIWAANTF | 91 | O43310 | |
| AIMTVFQILTGEDWN | 646 | Q15878 | |
| LDVTSTMLQQGWNAT | 306 | P12821 | |
| LNAGWLDSSRSLMEQ | 246 | Q9BQL6 | |
| GTLAQELFSMRSWSD | 266 | O95477 | |
| ASLGTFQQMWISKQE | 401 | O96019 | |
| ISMLTDDATIAAWNN | 3456 | Q96DT5 | |
| TSQDLAGFWDMLQLS | 866 | O14490 | |
| AGFWDMLQLSIENIS | 871 | O14490 | |
| MNSAEQTVTWLITLG | 1 | Q14155 | |
| FMQALQEVWSVNGRS | 156 | P46597 | |
| SEIIAFMVSISGWVL | 6 | P78369 | |
| TNWTAGLLVDSSEMI | 341 | Q9H4D0 | |
| VTSMFWVDAELGSDI | 146 | Q5RIA9 | |
| TVFQCITMEGWTDIL | 306 | Q00975 | |
| TWASQMNAVVYLGDI | 551 | O14646 | |
| NQVTLIGFTLMFWCE | 151 | Q8WXS4 | |
| DTWNLLLDFSTMIAD | 211 | Q96GG9 | |
| WVNLIMDTFASLALA | 886 | Q16720 | |
| DISWAAFNIIEVMSA | 71 | O14617 | |
| SVQSDIWSMGLSLVE | 241 | Q02750 | |
| VQSDIWSMGLSLVEL | 246 | P36507 | |
| WGATFMESSARENQL | 141 | Q8TAI7 | |
| RQLGASALFAQWMDV | 206 | Q9HCJ3 | |
| LGIAAIIVSQWDMFA | 256 | Q86V24 | |
| IAEGTSISEMWQNDL | 56 | Q16769 | |
| GDWTMVDENFSTLSL | 1226 | Q4ADV7 | |
| TLIRDMLLSGSSFNW | 401 | P10589 | |
| SGETVILQCWSDVMF | 136 | P43630 | |
| NIGVWQLAFETMSVI | 551 | Q9NW15 | |
| VIESFAINMETGWIT | 2856 | Q14517 | |
| SSEEWMILEFSQLGF | 281 | Q9UM21 | |
| AFGWLSSVLFETLMD | 366 | P53985 | |
| EFLMISNNGLVTTLW | 196 | Q8NGI4 | |
| MDTGNWSQVAEFIIL | 1 | Q8NGY5 | |
| STVKLWDMAADGQQF | 246 | Q5XUX1 | |
| LDMVGLAADWLTSTA | 186 | Q05329 | |
| IGQSQEMNTLFRFWS | 906 | Q6PKG0 | |
| METGNLTWVSDFVFL | 1 | P58180 | |
| SQLFLFTWSLGAEMV | 96 | Q8NGZ3 | |
| ALVLLWVQSSQGMVS | 2696 | Q9NU22 | |
| EASNMGWLTFTFSLQ | 991 | Q13045 | |
| RDFNSIFSDMGAWTL | 86 | O00165 | |
| EDSTSGNFWLLSLMR | 1691 | Q71F56 | |
| AMLGLTDAQVKVWFQ | 311 | Q14774 | |
| SMEEAGLEWNSALTA | 221 | Q9Y692 | |
| GLEWNSALTAAVTMA | 226 | Q9Y692 | |
| AMASRQVDIATQGWF | 1156 | Q92823 | |
| ISWTIEDMNGAFSGL | 371 | Q6UXM1 | |
| SGFLTLLDEESQMIW | 846 | Q9Y6X6 | |
| IQELFMRSSQTGDWT | 161 | Q3B7T1 | |
| VFDASGSRMAWTLIE | 526 | Q9UBS5 | |
| MDWDSAIQTGFTKLN | 56 | Q9Y5Z4 | |
| QEVTSNFLGAMWLIS | 311 | Q92952 | |
| FDVAFIGSIMTVWLS | 391 | Q86X55 | |
| NGDWTFQILVMLEIT | 181 | P05538 | |
| LNALEWAASSVEVMA | 446 | Q8NBM8 | |
| EGNSTLTLALVWQLM | 486 | Q14651 | |
| VVNVMFSFGSWNLSD | 571 | O60486 | |
| QMGTFLWQASAGIAV | 1006 | Q6ZWH5 | |
| LALGSQMTLVQVSNW | 106 | Q8IYA7 | |
| DQQDVTSNFLGAMWL | 486 | Q9UGI6 | |
| TSNFLGAMWLISITF | 491 | Q9UGI6 | |
| FMGNVTILSVIWIES | 41 | Q8NGJ5 | |
| EFVLLGLSNSWELQM | 11 | Q8NGD2 | |
| MAWSNQSAVTEFILR | 1 | Q96R72 | |
| AWNSSSVTMFILLGF | 6 | Q8NGJ0 | |
| DETLMESLTQFLGWS | 416 | P16499 | |
| LQMGQWTSVFLDNAS | 321 | Q4G0M1 | |
| NVAGLLSWTLAMAIF | 3266 | Q96JB1 | |
| NIGISIDSFQWKDMN | 1086 | Q5H8C1 | |
| NITAWMNAIGLIITA | 1141 | Q9ULK4 | |
| WEARLLQGSLMTATF | 386 | A0A1B0GTW7 | |
| LESLDRNWSVQTAGM | 426 | Q8IUZ0 | |
| SSETGLDMRVVQVWF | 191 | Q9UBR4 | |
| SSETGLDMRVVQVWF | 191 | Q969G2 | |
| MWTVQNRESLGLLSF | 1 | P18505 | |
| AVTMLSWIVAGQFAR | 171 | Q8WTR4 | |
| FVMLVQGSWQRSLQD | 11 | P01275 | |
| FVMNSVAFIGSNLWL | 986 | Q92887 | |
| LAWATSISIFENMNL | 121 | P59047 | |
| MGTDNQTWVSEFILL | 1 | Q13607 | |
| AETGVQSSDLQWMRN | 281 | Q15070 | |
| VVELLGNFLWTTDMA | 2731 | Q9Y4D8 | |
| ELFMISNNGLVTLLW | 196 | Q8NGJ1 | |
| MGNWSTVTEITLIAF | 1 | Q8NGM8 | |
| MVDIVTALGWNYVST | 206 | O00222 | |
| ILMNGLTESQFNSIW | 516 | Q86Y13 | |
| EQFAISEATLMAWSS | 131 | Q86XD5 | |
| WNSGIVIFNTTDTMI | 651 | Q96JM4 | |
| GQFQHALEELMSWLT | 6226 | Q9UPN3 | |
| ALGWDSVNLMDINSL | 1676 | Q7Z442 | |
| MGQTNVTSWRDFVFL | 1 | Q8NGY1 | |
| LDLTWCGLMFTLTTN | 166 | Q7RTS6 | |
| ELLMISNNGLVSWFV | 196 | Q8NGE8 | |
| MASGNLTWVTEFILV | 1 | Q8NGG1 | |
| SQRGWALMAVLLSAF | 571 | Q96JP2 | |
| AFLSSFVMNSGVWEE | 81 | O95456 | |
| FLVLASDGLWDMLSN | 406 | Q9P2J9 | |
| LFDASSSLVQMQWIA | 431 | O95876 | |
| VSGVLSDQMSARWLF | 66 | O43826 | |
| SDQMSARWLFSSGLL | 71 | O43826 | |
| FMDDVGQTLLNWASA | 391 | Q9ULT8 | |
| FFLDMTNWNLQAAIG | 46 | Q9H6K1 | |
| VMALVGNDAGWTQIS | 541 | A1L0T0 | |
| MASGSNWLSGVNVVL | 1 | Q9BWL3 | |
| AETLGEAWAALVSML | 106 | Q6ZP82 | |
| GQMSFWGATVITNLL | 136 | P00156 | |
| VLSSLLNQSENMAGW | 116 | Q9UFH2 | |
| TMIQEGLTWEGFQTA | 831 | Q9HCG7 | |
| QTTAIDMWSAGVIFL | 391 | O00311 | |
| AGAMVALAQNWTTVA | 431 | P09958 | |
| MSLFVLASKDGWVNI | 1371 | Q9P0X4 | |
| MAFLTLFQVSTGDNW | 1666 | Q9P0X4 | |
| KVMEAFNIDSNTGWI | 2861 | Q8TDW7 | |
| MAAAGNIETLWRISF | 156 | P56202 | |
| AGFALRSQMWTITGE | 66 | Q5JW98 | |
| FAALSGNKDITWVML | 86 | Q8IV38 | |
| MAGSDAEWVTIANNL | 1 | Q96GE4 | |
| LQSFSASEMEVSWNA | 811 | Q9UQ52 | |
| FFIIAVLMSAQESWA | 11 | P01903 | |
| FATMTNFSWLLAEAV | 211 | Q02643 | |
| FSGQLMNTWIDSLQA | 426 | Q92611 | |
| VTWQSSGEASNLVRM | 126 | Q6P0Q8 | |
| AGMTVIQWVSDFSER | 4471 | Q14204 | |
| SSDMNQSWVFTRVIG | 216 | Q5VTJ3 | |
| LTAAVWMSFAQAGIN | 321 | P60893 | |
| ITSADAVRNMEWATA | 541 | O95834 | |
| VTNVAFLWDDSMALT | 621 | O95834 | |
| VWKSFLEGTMQVAQS | 86 | O94868 | |
| MQAAWDKFLTGVAVV | 121 | Q6B0K9 | |
| VDAVDGWMLNSSAIR | 351 | Q5T4B2 | |
| QLTEVGTMNIFVYWT | 261 | O15382 | |
| SDNLWESISASMLLD | 226 | P54803 | |
| TSGWKDMFNVNVLAL | 111 | Q6UWP2 | |
| NTMESIQGLSSWCIE | 36 | Q5VT52 | |
| LAMNTWAQTIFQLGT | 561 | Q8WWT9 | |
| SVSAMFGSAVWQLVA | 106 | Q8WUM9 | |
| EVSAMVGSAVWQLIA | 91 | Q08357 | |
| SWMLDLFQSSVNVGF | 146 | O15244 | |
| TGFSFLQIFSISWEM | 181 | Q9H015 | |
| ANNITLWIFAVTAGM | 756 | Q9ULF5 | |
| DAENSMAWTRLSAGL | 61 | P09683 | |
| MTAAAASNWGLITNI | 1 | Q9HBR0 | |
| GELQVDASFMQTLWN | 186 | P21817 | |
| QMWKLGVVFTDNSFL | 4706 | Q92736 | |
| DELGLSNIWFIQANM | 486 | Q8NEC7 | |
| ADTVMFTIGALSEWL | 506 | O94829 | |
| TVFQCITMEGWTDVL | 356 | Q01668 | |
| SSMVWQVLEGLSQDS | 86 | Q2VPK5 | |
| DLSRVWQGMLNTTSE | 2796 | Q8TE73 | |
| AFWNITEMEVLSSLA | 541 | Q05469 | |
| GGLTESFIMTQNWLE | 121 | Q9P2P1 | |
| FSWSNITLLLTGLNM | 386 | P03905 | |
| VQAFSAQSGMKLEWS | 576 | Q9GZY0 | |
| LASGSMDNTVRLWDA | 726 | Q15542 | |
| MNISIWGFTESFLTS | 581 | Q99523 | |
| TFIADNELWVVTSFM | 136 | Q7RTN6 | |
| EMISGDWLESSISNL | 456 | Q06945 | |
| VWSMLADLEESLGTF | 486 | Q9HCS7 | |
| SGQLIANSIWDSVMR | 1211 | Q8WUY3 | |
| SSKLIQFWMSTVFGD | 226 | Q4G0N8 | |
| LMTTAAQAISGFFVW | 41 | Q9Y519 | |
| MTILGNTFILSLEWT | 211 | Q8N4F4 | |
| AAFEALMNGVTSWDV | 6 | Q9Y4C2 | |
| MNVIVVDWSRGATTF | 106 | Q6XZB0 | |
| FAVITAAQDVWMLLG | 111 | Q9NY64 | |
| QEAMAALRFLWGSEQ | 216 | Q9NY64 | |
| QVNSMSGWLVTDLIS | 521 | P25391 | |
| STQVVFWAGILQAQM | 151 | Q8NDX1 | |
| GSILASLSTFQQMWI | 1006 | P0CG39 | |
| VTVEAASLVQDWLMG | 1111 | O75182 | |
| LDFGTWTSMVELNLA | 396 | Q9UQ13 | |
| MTWVAIGASLFVSNI | 46 | P53794 | |
| NMERVFWLLSGSDSQ | 321 | Q86YJ6 | |
| SLLAAQGLWAQMSVF | 416 | Q8WX94 | |
| MSASGVLSFTQQGWE | 1 | Q8WU76 | |
| GLWIDMNEVSSFIQG | 501 | P14410 | |
| VLLATVTELSFDMWG | 176 | Q96K37 | |
| VTELSFDMWGLVSAL | 181 | Q96K37 | |
| FSMEALELQGAISWE | 76 | Q9C0C4 | |
| GLALVSGWATFQQMS | 11 | Q4LDE5 | |
| MGNWTAAVTEFVLLG | 1 | Q8NGC5 | |
| SSWGEALFLMLQTIT | 101 | O75352 | |
| TMNLFGQTTSVWIGL | 1011 | Q13018 | |
| FGSSVQMVWLNAQFD | 1306 | Q13018 | |
| VEVQSWLRMSTGFSA | 701 | Q8WXE9 | |
| MAALGVQSINWQTAF | 1 | Q08188 | |
| GMATENLWLSDVFIE | 111 | Q70Z44 | |
| GFLMTSEWAKANEVA | 706 | Q7Z7M1 | |
| SSNIWALRQIADFMA | 81 | P35612 | |
| VMSSIGNDLANSIWE | 531 | A6NIR3 | |
| AMLDVAANQGWLVTV | 1926 | Q8N3C0 | |
| STFASTMQLAELWLE | 856 | Q70JA7 | |
| VWDQSALDVGLTMQL | 616 | P48736 | |
| TLWDLETQGMQCFSL | 451 | Q96JI7 | |
| LWGFQQIESSMTDLD | 281 | Q86WB0 | |
| NSNSFIWTDGLQMLF | 106 | Q9NPI0 | |
| WLATQTMNFTGQLGA | 76 | Q63HM9 | |
| ALMLDSTFSILQTWD | 531 | Q63HN8 | |
| TTGGSVNFIMLINWT | 51 | Q9H6R6 | |
| ITMQIVGDLSFAWQL | 546 | Q12768 | |
| FAWQLIDSFTSIMQE | 556 | Q12768 | |
| VMLENFALLSSVGCW | 36 | O43361 | |
| GQEMFWQEMTSTGAL | 141 | Q86W11 | |
| LFTEGMWLSANLTVQ | 41 | Q6ZVK1 | |
| EMEWSDNSLLLASLS | 506 | O60673 | |
| AADVWSLGVALFTML | 241 | Q96RU7 | |
| GFQMWLEENRSNILS | 1021 | O75717 | |
| GETLLSMNWAIVADI | 391 | Q9H2V7 | |
| IFSLATNEMWRSGDS | 56 | Q04837 | |
| VSTDGFMLNFLWVLQ | 681 | O95155 | |
| LSWMATDGIFETFTI | 1456 | P24821 | |
| GSMFSLITWNIDGLD | 111 | O95551 | |
| AALNTLAGYIDWVSM | 226 | Q9HAV4 | |
| WEDNSVIFLLVQSMV | 336 | P21359 | |
| ATSEMNTAEDWGLIL | 16 | Q92783 | |
| NWTSLMAAVADVTLQ | 2311 | Q709C8 | |
| ESLMDGIFTTQSDVW | 2131 | P08922 | |
| QQNFLELWSEILMTG | 1881 | Q12888 | |
| ATDGSLAFWDLTTML | 936 | Q9NNW5 | |
| TWLSASDLTNIAIGM | 351 | Q5H9I0 | |
| FINAALSWLGDMVDI | 441 | O00337 | |
| LTMGDLISFAWQISQ | 846 | P07949 | |
| TEVGVYALDSIMQTW | 926 | Q9HCJ5 | |
| LLQQWGAEITMTATL | 96 | P63123 | |
| LQVATFNGWITIMNS | 1136 | Q01118 | |
| FNGWITIMNSAIDSV | 1141 | Q01118 | |
| TEFQMRLLWGSQGAS | 816 | Q8N5H7 | |
| FMQSAEVGTIFALSW | 206 | Q96BZ9 | |
| RVLSTAQFLWMLGQA | 1506 | Q92508 | |
| YSIWTTDIGTELAMA | 366 | Q5T9L3 | |
| LATGSMDKTVNIWQF | 296 | Q8N9V3 | |
| TAGEAVSWNSIFILM | 256 | Q5BJD5 | |
| ISMFVSSDAGNTWRQ | 566 | Q8WY21 | |
| DSLGQLVDWTMQALN | 426 | Q69YN4 | |
| WNLAVIQLFSAEGMD | 956 | Q69YN4 | |
| ISEETLANNTWSLML | 1081 | Q69YN4 | |
| VMLENFALLSSVGCW | 36 | P17021 | |
| ADFVLQWMDVGLSSE | 161 | P49815 | |
| EDSMASTVLWTVFLG | 621 | Q8IU80 | |
| FWMQSNAVVAVLAGI | 356 | Q9NX78 | |
| QTNDFIILAVWGMLA | 481 | Q9NS93 | |
| LSEQTAALGTGWESM | 16 | Q96N77 | |
| VGWDMQNVITLDTSF | 196 | Q12879 | |
| MWTISINSAINDGRT | 326 | P16519 | |
| LDMATSWQVFDILNG | 776 | P19838 |